Evidence map›Paper›PMID 30175728›Full record

ArticleInternal medicine (Tokyo, Japan)2018

Primary Oral Mucormycosis Due to Rhizopus microsporus after Allogeneic Stem Cell Transplantation.

Hikaru Sakamoto, Hidehiro Itonaga, Yasushi Sawayama, Jun Taguchi, Tomomi Saijo, Sayaka Kuwatsuka, Mikiko Hashisako, Naoe Kinoshita, Masao Oishi, Hanako Doi and 7 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Hikaru SakamotoDepartment of Hematology, Nagasaki University Hospital, Japan.
Hidehiro ItonagaDepartment of Hematology, Nagasaki University Hospital, Japan.
Yasushi SawayamaDepartment of Hematology, Nagasaki University Hospital, Japan.
Jun TaguchiDepartment of Hematology, Japanese Red Cross Nagasaki Genbaku Hospital, Japan.
Tomomi SaijoDepartment of Respiratory Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Japan.
Sayaka KuwatsukaDepartment of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Mikiko HashisakoDepartment of Pathology, Nagasaki University Hospital, Japan.
Naoe KinoshitaDepartment of Pathology, Nagasaki University Hospital, Japan.
Masao OishiDepartment of Plastic and Reconstructive Surgery, Graduate School of Biomedical Sciences, Nagasaki University, Japan.
Hanako DoiDepartment of Plastic and Reconstructive Surgery, Graduate School of Biomedical Sciences, Nagasaki University, Japan.
Kosuke KosaiDepartment of Laboratory Medicine, Nagasaki University Hospital, Japan.
Katsutaro NishimotoDepartment of Dermatology, Nagasaki Ekisaikai Hospital, Japan.
Katsumi TanakaDepartment of Plastic and Reconstructive Surgery, Graduate School of Biomedical Sciences, Nagasaki University, Japan.
Katsunori YanagiharaDepartment of Laboratory Medicine, Nagasaki University Hospital, Japan.
Hiroshi MukaeDepartment of Respiratory Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Japan.
Koichi IzumikawaDepartment of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Yasushi MiyazakiDepartment of Hematology, Nagasaki University Hospital, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We herein report a rare case of oral mucormycosis following allogeneic hematopoietic stem cell transplantation. Oral mucormycosis due to Rhizopus microsporus manifested as localized left buccal mucositis with a 1-cm black focus before neutrophil recovery. Combination therapy with liposomal amphotericin B was initiated and surgical debridement was performed; however, the patient died due to progressive generalized mucormycosis. Considerable attention needs to be paid to the diagnosis and management of oral mucormycosis in post-transplant patients, thereby suggesting the importance of fully understanding the risk factors.

Indexed as

Amphotericin BAntifungal AgentsCombined Modality TherapyDebridementFatal OutcomeHematopoietic Stem Cell TransplantationHumansLeukemia, Myeloid, AcuteMaleMiddle AgedMucormycosisRhizopusRisk FactorsStomatitisAmphotericin BAntifungal Agentsliposomal amphotericin Bacute myeloid leukemiaallogeneic hematopoietic stem cell transplantationoral mucormycosis

Identifiers

PMID30175728
PMCPMC6172532

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.